Profitability Metrics

Gross Margin
51.69%
Operating Margin
22.07%
Net Margin
17.70%

Efficiency Metrics

Revenue per Expense Ratio
1.28
R&D as % of Revenue
2.38%

Earnings Quality

EBITDA Margin
27.01%
Income Tax Rate
20.19%
EPS
6.3000000000

Balance Sheet Analysis

Current Ratio
0.73
Cash Ratio
0.28
Working Capital
$-8.92B
Debt to Equity
0.66
Debt to Assets
27.27%
Equity Ratio
41.09%

Cash Flow Analysis

Operating Cash Flow Ratio
23.61%
Free Cash Flow Ratio
19.66%
CapEx to Revenue
3.95%
Dividends Paid
$9.31B
Stock Buybacks
$5.01B
Total Shareholder Returns
$14.32B
Cash Position Change
14.99%

Key Takeaways (2024 FY)

  • Maintained positive net income growth despite revenue changes
  • Increased dividend payments by 3.83%

Detailed Growth Metrics

Core Performance

Revenue
2.48%
Net Income
1.54%
EPS
3.79%
Operating Income
2.27%

Operational Efficiency

R&D Expenses
0.00%
SG&A Expenses
10.39%
Operating Cash Flow
17.79%
Free Cash Flow
19.86%

Balance Sheet Health

Assets
1.28%
Debt
-3.58%
Book Value per Share
7.79%
Inventory
-0.81%

Shareholder Returns

Dividends per Share
3.83%
Shares Outstanding
-0.34%

Long Term Trends

3Y Revenue/Share
15.35%
5Y Revenue/Share
31.71%
3Y Dividend/Share
17.74%
5Y Dividend/Share
31.74%